Dialysis access graft registry using a processed donor artery
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows people with kidney failure who need dialysis access, when they receive an AV (artery-to-vein) access graft made from a processed donor artery. It’s meant to track safety and how well the new graft performs in real-world care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older (male or female).
- You have end-stage kidney disease or kidney problems that require hemodialysis.
- You need dialysis access, and an AV access graft in an arm/upper body is an option for you.
- You (or your legal guardian) can understand the study and sign consent, and you can follow study visit requirements.
- You agree to let the study use and share your health information for the research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This study tests a new type of graft (aXess) for dialysis access in people with kidney failure who cannot get a fistula. The graft is placed in the arm to help with blood flow during dialysis.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
This study looks at blood flow and sounds in new arteriovenous fistulas (AVFs) during dialysis. If you need a new AVF in your forearm, this trial may help doctors understand how to make your fistula work better.
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
This trial tests a new artificial graft device designed to create a reliable access point in your arm for hemodialysis if you have end-stage kidney disease. The graft connects an artery to a vein, allowing easier and safer blood flow during dialysis treatments.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.